首页> 外文期刊>Naunyn-Schmiedeberg's Archives of Pharmacology >Pharmacokinetic and pharmacodynamic studies of drug interaction following oral administration of imipramine and sodium alginate in rats
【24h】

Pharmacokinetic and pharmacodynamic studies of drug interaction following oral administration of imipramine and sodium alginate in rats

机译:口服丙咪嗪和海藻酸钠对大鼠药物相互作用的药代动力学和药效学研究

获取原文
获取原文并翻译 | 示例
           

摘要

Recently, the use of health foods has increased due to growing interest in health maintenance. Previous in vitro studies have shown some drugs to be adsorbed by sodium alginate, a dietary fiber, and that such adsorption was marked with tricyclic antidepressants, such as imipramine. This study investigated the pharmacokinetic and pharmacological interactions between imipramine and sodium alginate in rats. The simultaneous administration of imipramine (30 mg/kg, oral (p.o.)) and sodium alginate (3.0%, p.o.) decreased the antidepressant-like activity of imipramine in a forced swimming test. In the rats administrated imipramine and 0.3%, 1.0%, or 3.0% sodium alginate, the geometric mean ratio of the C max values of imipramine was 72% [90% confidence intervals (CI) = 53–91%], 64% (90% CI = 47–80%), and 58% (90% CI = 50–67%), respectively. The geometric mean ratio of the AUC0–6 values of imipramine were 68% (90% CI = 56–80%), 74% (90% CI = 60–89%), and 87% (90% CI = 73–102%), respectively. The decrease in C max and AUC0–6 was judged to be significant with a 90% CI outside the 80–125% boundaries. In addition, the T max value of imipramine significantly increased (P < 0.05) by coadministration with 3.0% sodium alginate. These results suggested that simultaneous administration of sodium alginate decreased the serum concentration and pharmacological action of imipramine, through a delay in its absorption. Although the clinical relevance of these findings is unclear, it is important to pay considerable attention to the interactions between imipramine and sodium alginate.
机译:近来,由于对健康维持的兴趣日益增加,健康食品的使用已经增加。先前的体外研究表明,某些药物会被海藻酸钠(一种膳食纤维)吸附,这种吸附以三环抗抑郁药(如丙咪嗪)为标志。这项研究调查了丙咪嗪和海藻酸钠之间在大鼠体内的药代动力学和药理学相互作用。在强迫游泳试验中,同时给予丙咪嗪(30 mg / kg,口服(口服))和海藻酸钠(3.0%,口服)降低了丙咪嗪的抗抑郁样活性。在使用丙咪嗪和0.3%,1.0%或3.0%海藻酸钠的大鼠中,丙咪嗪的C max 值的几何平均比为72%[90%置信区间(CI)= 53– 91%],64%(90%CI = 47–80%)和58%(90%CI = 50–67%)。丙咪嗪的AUC 0-6 值的几何平均比分别为68%(90%CI = 56-80%),74%(90%CI = 60-89%)和87% (90%CI = 73-102%)。 C max 和AUC 0-6 的下降被认为是显着的,CI值在80–125%边界之外时为90%。此外,与3.0%海藻酸钠合用时,丙咪嗪的T max 值显着增加(P <0.05)。这些结果表明,同时给药海藻酸钠通过延迟吸收降低了丙咪嗪的血清浓度和药理作用。尽管这些发现的临床相关性尚不清楚,但重要的是要注意丙咪嗪和海藻酸钠之间的相互作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号